PAR-24-269-Full-Announcement.html

This document is a full announcement for the NIDA Animal Genomics Program (U01 Clinical Trial Not Allowed) federal grant opportunity, Solicitation Number PAR-24-269.

The purpose of this grant is to identify genetic, genomic, and molecular (epi)genetic variants that underlie phenotypes associated with addictive behaviors, vulnerability to substance use disorders, and comorbidities. NIDA encourages applications that take genomics, multi-omics, and/or data-based approaches to uncover novel mechanisms contributing to the substance use disorder trajectory and inform potential therapeutic strategies. The funding instrument is a cooperative agreement, and eligible applicant types include a wide range of organizations such as universities, non-profits, small businesses, and state/local governments. The grant program is administered by the National Institutes of Health under CFDA 93.279 - Drug Use and Addiction Research Programs. No additional details are provided about award amounts, response due dates, or anticipated award dates.